# DESCRIPTION

## TECHNICAL FIELD

- relate to enhancer for promoter

## BACKGROUND ART

- motivate gene therapy
- limitations of prior art

## SUMMARY OF THE INVENTION

### Problems to be Solved by the Invention

- motivate enhancer for viral promoter

### Solutions to the Problems

- introduce intron for MIE gene
- describe enhancer activity
- compare with CMV promoter
- describe combination with 6MIE promoter
- summarize advantages
- provide item 1
- provide item 2
- provide item 3
- provide item 4
- provide item 5

### Advantageous Effects of Invention

- summarize benefits

## MODE FOR CARRYING OUT THE INVENTION

- define conventions for specification

### DEFINITION

- define HHV
- define herpesvirus
- define protein and related terms
- define polynucleotide and related terms
- define gene
- define open reading frame
- define RNAi
- define factor causing RNAi
- define corresponding amino acid and nucleic acid
- define corresponding gene, promoter, and intron
- define isolated substance
- define purified substance
- define homology
- define stringent hybridization conditions
- define hybridizable polynucleotide
- define search
- define expression
- define amino acid abbreviations
- define nucleotide abbreviations
- define fragment
- define polypeptide variant
- define variant
- define allele
- define allelic variant
- define species homolog
- define orthologs
- define functional variant
- describe degenerate codon substitutions
- describe RNAi techniques
- describe hybridization methods
- describe identity comparison and homology calculation
- define conservative variant
- explain silent alterations
- describe amino acid substitutions
- describe amino acid additions
- describe amino acid deletions
- describe amino acid modifications
- define nucleic acid form
- describe obtaining nucleic acid
- define substitution, addition, or deletion
- describe techniques for substitution, addition, or deletion
- define promoter
- describe promoter region
- define MIE
- define MIE promoter
- define 6MIE
- define IE1 of 6MIE
- define 6MIE promoter
- describe identification method of promoter
- define MIE promoter of HHV-6B
- describe preferred MIE promoter of HHV-6B
- define constructive expression
- describe enhancer
- define intron
- define operatively linked
- define nucleic acid construct
- describe preferred expression cassettes
- define vector
- describe BAC vector
- define selective marker
- describe fluorescent markers
- describe drug selective markers
- define expression vector
- define foreign gene
- define cytokine
- define growth factor
- describe homology with foreign gene
- define expression of gene product
- define reduction of expression
- define increase of expression
- define induction of expression
- define specific expression
- describe methods for introducing recombinant vector
- describe transitional expression of Cre enzyme
- describe detection or quantification of gene expression
- describe gene analysis methods
- define expression amount
- define change in amount of expression
- define transformation, transduction, and transfection
- define transformant
- describe examples of prokaryotic cells
- describe examples of animal cells
- define animal
- define tissue
- define body organ
- define transgenic
- describe production techniques of transgenic organisms
- define screening
- define chip
- describe use of herpesvirus promoters
- define effective amount
- describe determination of effective amount
- describe usefulness of present invention
- define pharmaceutically acceptable carrier
- describe examples of pharmaceutically acceptable carrier
- motivate use of pharmaceutically acceptable carrier
- describe instructions for treatment method
- define instructions
- describe preparation of instructions
- motivate use of multiple pharmaceutical agents
- describe culturing methods
- reference culturing methods manual
- introduce gene therapy
- describe gene therapy method
- reference gene therapy reviews
- introduce demonstration of therapeutic activity
- describe in vitro assays
- describe in vivo assays
- introduce administration for therapy/prevention and composition
- describe administration methods
- describe pharmaceutical composition
- describe examples of pharmaceutically acceptable carrier
- describe formulation materials
- describe administration routes
- describe dosage formulation
- describe preparation and storage of pharmaceutical agent
- describe determination of sugar chain composition amount
- describe determination of administration frequency
- introduce general techniques used in specification
- describe microfabrication techniques
- describe molecular biology, biochemistry, microbiology, and sugar chain scientific procedures

## DESCRIPTION OF PREFERRED EMBODIMENTS

- introduce enhancer for promoter

### (Enhancer for Promoter)

- define enhancer for promoter
- describe structure of enhancer
- describe function of enhancer
- describe selectivity of enhancer
- describe application of enhancer
- describe advantages of enhancer
- describe limitations of prior art
- describe unexpected effect of enhancer
- describe sequence of enhancer
- describe variations of enhancer
- describe biological activity of enhancer
- describe identity of enhancer
- describe region of enhancer effect
- describe use of enhancer

### (Promoter)

- define promoter with improved activity
- describe structure of promoter
- describe function of promoter

### (Gene Construct)

- define gene construct
- describe structure of gene construct
- describe function of gene construct
- describe application of gene construct
- describe advantages of gene construct
- describe limitations of prior art
- describe unexpected effect of gene construct
- describe sequence of gene construct
- describe variations of gene construct
- describe biological activity of gene construct
- describe identity of gene construct
- describe region of gene construct effect
- describe use of gene construct
- describe cells targeted by gene construct
- describe foreign gene in gene construct

### (Method for Enhancing Expression of Gene in Cell)

- describe method for enhancing gene expression
- describe kit for enhancing gene expression

### (Use)

- describe use of enhancer for promoter
- describe pharmaceutical composition
- describe antigen-encoding sequence
- describe DNA vaccine
- describe treatment of disease
- describe nucleic acid sequences for treatment
- describe production of pharmaceutical composition

## EXAMPLES

- describe examples of the invention

### Example 1

- introduce MIE promoter of HHV-6
- describe materials and methods
- conduct reporter assay with luciferase
- analyze results of reporter assay
- consider implications of results

### Example 2

- examine poly-A addition reaction derived from herpes virus
- describe materials and methods
- confirm expression of DsRed2

### Example 3

- construct specific deletion system
- prepare cells for experiment
- produce siRNA expression retrovirus vector
- infect cells with retrovirus vector
- confirm gene introduction
- confirm knockdown of gene expression

### Example 4

- introduce nucleic acid molecule encoding gene for expression

## INDUSTRIAL APPLICABILITY

- describe industrial applicability of the invention

